A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.

In conclusion, the novel seven-gene signature could serve as a robust biomarker for prognosis and a potential indicator of immunotherapy response in melanoma.
PMID: 32731180 [PubMed - as supplied by publisher]

Source: International Immunopharmacology - July 26, 2020 Category: Allergy & Immunology Authors: Tian M, Yang J, Han J, He J, Liao W Tags: Int Immunopharmacol Source Type: research